| Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia? HS Shehata, MS El-Tamawy, NM Shalaby, G Ramzy The journal of headache and pain 14, 1-6, 2013 | 113 | 2013 |
| Mapping local patterns of childhood overweight and wasting in low-and middle-income countries between 2000 and 2017 DK Kinyoki, JM Ross, A Lazzar-Atwood, SB Munro, LE Schaeffer, ... Deakin University, 2020 | 74 | 2020 |
| Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial HS Shehata, EH Esmail, A Abdelalim, S El-Jaafary, A Elmazny, A Sabbah, ... Journal of pain research, 771-777, 2016 | 54 | 2016 |
| Prevalence of primary headache disorders in Fayoum Governorate, Egypt NA El-Sherbiny, M Masoud, NM Shalaby, HS Shehata The Journal of Headache and Pain 16, 1-8, 2015 | 50 | 2015 |
| Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17 KE Wiens, PA Lindstedt, BF Blacker, KB Johnson, MM Baumann, ... The Lancet Global Health 8 (8), e1038-e1060, 2020 | 45 | 2020 |
| Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study SM Hamdy, M Abdel-Naseer, NM Shalaby, AN Elmazny, AA Nemr, ... Neuropsychiatric Disease and Treatment, 1895-1903, 2017 | 42 | 2017 |
| Mapping local patterns of childhood overweight and wasting in low-and middle-income countries between 2000 and 2017 Nature medicine 26 (5), 750-759, 2020 | 30 | 2020 |
| Corticobasal degeneration: clinical characteristics and multidisciplinary therapeutic approach in 26 patients HS Shehata, NM Shalaby, EH Esmail, E Fahmy Neurological Sciences 36, 1651-1657, 2015 | 25 | 2015 |
| Interferon-beta-induced headache in patients with multiple sclerosis: frequency and characterization A Elmazny, SM Hamdy, M Abdel-Naseer, NM Shalaby, HS Shehata, ... Journal of Pain Research, 537-545, 2020 | 20 | 2020 |
| Micro-RNA-96 and interleukin-10 are independent biomarkers for multiple sclerosis activity MS Sedeeq, EMA El-Nahrery, N Shalaby, M Hussein, H Shehata, ... Journal of the Neurological Sciences 403, 92-96, 2019 | 19 | 2019 |
| Clinical patterns and outcomes of status epilepticus in patients with tuberous sclerosis complex HS Shehata, HM AbdelGhaffar, M Nasreldin, A Elmazny, A Abdelalim, ... Therapeutics and clinical Risk management, 779-785, 2017 | 19 | 2017 |
| Managing disease-modifying therapies and breakthrough activity in multiple sclerosis patients during the COVID-19 pandemic: toward an optimized approach SM Hamdy, M Abdel-Naseer, HS Shehata, A Hassan, A Elmazny, ... Therapeutics and Clinical Risk Management, 651-662, 2020 | 18 | 2020 |
| Neurological manifestations in a cohort of Egyptian patients with COVID-19: a prospective, multicenter, observational study DA Mekkawy, S Hamdy, M Abdel-Naseer, HS Shehata, AA Halfawy, ... Brain Sciences 12 (1), 74, 2022 | 17 | 2022 |
| Knowledge and attitude towards stroke among workers in Cairo University Hospitals H Shehata, S Ahmed, A Abdelalim, N El Sherbiny The Egyptian Journal of Neurology, Psychiatry, and Neurosurgery 53 (1), 2016 | 16 | 2016 |
| Reliability and validity of Arabic version of the brief international cognitive assessment for multiple sclerosis: Egyptian dialect M Farghaly, DW Langdon, NM Shalaby, HS Shehata, NT Abokrysha, ... The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 57, 1-8, 2021 | 15 | 2021 |
| Development and validation of an Arabic-language headache questionnaire for population-based surveys NA El-Sherbiny, HS Shehata, H Amer, A Elmazny, M Masoud, H Helmy, ... Journal of Pain Research, 1289-1295, 2017 | 15 | 2017 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 13 | 2023 |
| Changes in migraine characteristics over 30 days of Ramadan fasting: A prospective study AH Ragab, NA Kishk, A Hassan, O Yacoub, L El Ghoneimy, A Elmazny, ... Headache: The Journal of Head and Face Pain 61 (10), 1493-1498, 2021 | 12 | 2021 |
| Management strategies of patients with neuromyelitis optica spectrum disorder during the COVID-19 pandemic era SM Hamdy, M Abdel-Naseer, HS Shehata, NM Shalaby, A Hassan, ... Therapeutics and Clinical Risk Management, 759-767, 2020 | 11 | 2020 |
| Oromandibular dystonia in yemeni patients with khat chewing: a response to botulinum toxin treatment HS Shehata, MS El-Tamawy, N Mohieldin, M Edrees, S Bohlega Neurology international 6 (2), 5385, 2014 | 11 | 2014 |
Nevin Shalabyprofessor of neurologyVerified email at kasralainy.edu.eg
